Treatment of Lennox-Gastaut syndrome

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 2, 2013, Pages

  Hancock, Eleanor C ^a   Cross, J Helen ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CINROMIDE; CLOBAZAM; FELBAMATE; LAMOTRIGINE; PLACEBO; RUFINAMIDE; TOPIRAMATE; ANTICONVULSIVE AGENT;

ADD ON THERAPY; ATONIC SEIZURE; ATYPICAL ABSENCE SEIZURE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; HUMAN; LENNOX GASTAUT SYNDROME; MORTALITY; MYOCLONUS SEIZURE; OUTCOME ASSESSMENT; PARTIAL ONSET SEIZURE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SEIZURE; SYSTEMATIC REVIEW; TONIC CLONIC SEIZURE; TONIC SEIZURE; CHILD; ELECTROENCEPHALOGRAPHY; GENERALIZED EPILEPSY; INFANTILE SPASM; INTELLECTUAL IMPAIRMENT; MALE; ONSET AGE; PERSONALITY DISORDER; PHYSIOLOGY; SYNDROME; WAKEFULNESS;

AGE OF ONSET; ANTICONVULSANTS; CHILD; ELECTROENCEPHALOGRAPHY; EPILEPSY, GENERALIZED; HUMANS; INTELLECTUAL DISABILITY; MALE; PERSONALITY DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPASMS, INFANTILE; SYNDROME; WAKEFULNESS;

EID: 84885134015     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003277.pub3     Document Type: Review

References (20)

1. Anonymous. Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut syndrome. The Group for the Evaluation of Cinromide in the Lennox-Gastaut syndrome. Epilepsia 1989;30(4):422-9. [MEDLINE: 89325225]
2. Anonymous. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). The Felbamate Study Group in Lennox Gastaut syndrome. New England Journal of Medicine 1993;328(1):29-33. [MEDLINE: 93096004]
3. Conry J, Ng Y, Paolicchi JM, Kernitsky L, Mitchell WG, Ritter FJ, et al.Clobazam in the treatment of Lennox Gastaut syndrome. Epilepsia 2009;50(5):1158-66.
4. Conry J, Ng Y, Drummond R, Stolle J, Sagar S. Efficacy and safety of clobazam in the treatment of seizures associated with Lennox Gastaut syndrome: results of a phase III trial (abstract no: 1.283). Proceedings of the 64th Annual Meeting of the American Epilepsy Society. December 3-7, 2010, San Antonio, TX. www.aesnet.org/go/publications/aes-abstracts/abstract-search/mode/display/st/clobazam/sy/2010/sb/All/id/12483 (accessed 28 April 2012).
5. Eriksson AS, Nergardh A, Hoppu K. The efficacy of lamotrigine in children and adolescents with refractory generalised epilepsy: a randomised, double blind, crossover study. Epilepsia 1998;39(5):495-501.
6. Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008;70(21):1950-8.
7. Glauser T, Santana B V, Wang W, Narurkar M. Early and sustained response to rufinamide as adjunctive therapy for seizures associated with Lennox Gastaut syndrome. Epilepsia 2009;50 (suppl 11):261.
8. Inanaga K, Kumashiro H, Fukyama Y, Ohtahara S, Shirouzu M. Clinical study of oral administration of DN-1417, a TRH analog, in patients with intractable epilepsy. Epilepsia 1989;30(4):438-45. [MEDLINE: 89325227;: 1989194763]
9. Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalised seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. New England Journal of Medicine 1997;337(25):1807-12. [MEDLINE: 98051155;: 1998002039]
10. Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G. A double-blind, randomized trial of topiramate in Kennox-Gastaut syndrome. Topiramate YL Study Group. Neurology 1999;52(9):1882-7. [MEDLINE: 99297948;: 1999198021]
11. Jensen PK. Felbamate in the treatment of Lennox-Gastaut syndrome. Epilepsia 1994;35 (suppl)(5):S54-7. [MEDLINE: 94313954;: 1994265566]
12. Vajda FJ, Bladin PF, Parsons BJ. Clinical experience with clobazam: a new 1, 5 benzodiazepine in the treatment of refractory epilepsy. Clinical and Experimental Neurology 1985;21:177-82. [MEDLINE: 87188404]
13. Vassella F, Rudeberg A, Da Silva V, Pavlincova E. Double-blind study on the anticonvulsive effect of phenobarbital and valproate in the Lennox syndrome [Doppletblind-Untersuchung uber die antikonvulsive Wirkung von Phenobarbital und Valproat beim Lennox-Syndrom]. Schweizerische Medizinische Wochenschrift 1978;108(19):713-6. [MEDLINE: 78321217]
14. Aicardi J. Lennox-Gastaut syndrome. In: Wallace editor(s). Epilepsy in Children. First Edition. London: Chapman & Hall Medical, 1996:249-62.
15. Arzimanoglou A, French J, Blume WT, Cross J, Ernst JP, Feucht M, et al.Lennox Gastaut Syndrome: a consensus approach on diagnosis, assessment, management and trial methodology. Lancet Neurology 2009;8(1):82-93.
16. Beaumanoir A, Blume W. The Lennox-Gastaut syndrome. In: Roger J, Bureau M, Dravet C, Tassinari C, Wolf P editor(s). Epileptic Syndromes in Infancy, Childhood and Adolescence. 4th Edition. London: John Libby Eurotext, 2005:125-48.
17. Berg A, Scheffer I. New concepts in classification of the epilepsies: entering the 21st century. Epilepsia 2011;52(6):1058-61.
18. The European Parliament and the Council of the European Union. Regulation (EC) No 1901/2006 of the European Council and of the Council of 12th December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. www.emea.europa.eu/htms/human/paediatrics/regulation.htm 2006.
19. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org.
20. Patwardhan RV, Strong B, Bebin EM, Mathisen J, Grabb PA. Efficacy of vagal nerve stimulation in children with medically refractory epilepsy. Neurosurgery 2000;47:1353-7.